Trials / Completed
CompletedNCT04118049
Vaginal Probiotics and Pessaries and Their Impact on the Vaginal Microenvironment
The Effect of Vaginal Probiotics on the Vaginal Microenvironment in Patients Using Vaginal Pessaries: a Randomized Controlled Trial.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 141 (actual)
- Sponsor
- Hartford Hospital · Academic / Other
- Sex
- Female
- Age
- 18 Years – 89 Years
- Healthy volunteers
- Not accepted
Summary
In this study, the investigators are evaluating the effect of vaginal probiotics on the bothersome side effects of pessary use and the impact on the vaginal microenvironment (lactobacilli, anaerobic bacteria, mobiluncus bacteria, WBCs, cellular debris, epithelial cells, and BVAB-1), and inflammatory environment (cytokines).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | BiopHreshTM vaginal probiotic supplement (Good Clean Love, Inc. Eugene, OR) and RestoreTM gel. | BiopHreshTM is a vaginal probiotic supplement that is offered over the counter and contains four different lactobacilli strains (L. crispatus, L. gasseri, L. jensenii, and L. rhamnosus). RestoreTM is a moisturizing personal lubricant that has been on the market for three years. Participants will use 1 probiotic capsule with RestoreTM gel nightly three times weekly. |
| OTHER | Standard Care | Standard care arm is standard care for pessary use. Pessary maintenance will be performed standardly by their provider. |
Timeline
- Start date
- 2019-10-30
- Primary completion
- 2021-05-30
- Completion
- 2021-05-30
- First posted
- 2019-10-07
- Last updated
- 2022-03-25
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04118049. Inclusion in this directory is not an endorsement.